Congratulations Gary V. Gordon, MD, FACP, FACR, Thomas Harder, MD & Amy Lundholm, DO, Main Line Today’s 2019 TOP DOCTOR WINNERS!
FOR IMMEDIATE RELEASE
October 28, 2019 Wynnewood, PA… Gary V. Gordon, MD, FACP, FACR, owner of Main Line Rheumatology practice, and chief of Rheumatology, Lankenau Medical Center, announces that Main Line Rheumatology is now called, Main Line Rheumatology & Osteoporosis.
Only our name has changed! The practice of Main Line Rheumatology & Osteoporosis is still independently owned, and its doctors, staff and office locations at Lankenau Medical Center, and Main Line Health Center, in Broomall remain the same.
Why the practice name change? Dr. Gary Gordon said, “Over the last number of years, we have seen a dramatic rise in the number of osteoporosis patients we see, and patients with osteopenia or other fracture risks. Osteoporosis has become our rheumatology practice’s largest growing sub-medical specialty. Adding “osteoporosis” to Main Line Rheumatology, creates a more defining description of our practice, today.”
Osteoporosis is a common rheumatology disease.
According to recent statistics from the National Osteoporosis Foundation, osteoporosis is responsible for an estimated two million broken bones per year, yet nearly 80 percent of older Americans who suffer bone breaks are not tested or treated for osteoporosis. Approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at increased risk. One in two women, and up to one in four men over age 50, will break a bone due to osteoporosis.
Dr. Gordon added, “Our doctors and staff are committed to treating our osteoporosis patients. I encourage individuals who have noticeable symptoms (i.e. back pain, fractured or collapsed vertebra, loss of height over time, stooped posture, or a bone that breaks much more easily than expected) to make an appointment with a rheumatologist for diagnosis. Pro-active testing and treatment could stave off fractures, or full-blown disease.”
Rheumatoid arthritis — a chronic autoimmune condition that causes pain and stiffness in the joints affects between 0.3% and 1% of the world’s population, according to the World Health Organization (WHO). Now, a new review appearing in the journal Frontiers in Nutrition shows that following a plant based diet can be a useful intervention when it comes to coping with this condition, as it triggers some helpful biological changes, stating, “Symptoms may improve or even disappear.”
Many rheumatologic diseases are difficult to sort out in the beginning. New York Times medical writer, Jane Brody, describes polymyalgia, an inflammatory disease affecting muscles and connective tissue in the shoulder/pelvic region, and the overlapping and more serious temporal or giant cell arteritis, involving blood vessels to the scalp and the eyes with potential risk of blindness. Talk to your primary care physician and consider seeing a rheumatologist if you have these symptoms.
To accommodate our patients, Main Line Rheumatology has increased its hours to better serve you!
LANKENAU MEDICAL CENTER
Monday 9am – 5:30pm
Tuesday and Wednesday 8am- 4pm
Thursday 9am – 4pm
Friday 8am- 4pm
MAIN LINE HEALTH CENTER, Broomall
Tuesday, Wednesday and Friday 9am – 4pm
Here are the hands of an 83-year-old patient with Rheumatoid Arthritis (RA). Dr. Gary Gordon says that RA does not have to be as debilitating a condition, as you might think. Watch what this patient does with this telephone book; it’s a true testament to motivation and RA treatment!
Video of 83-year-old patient with Rheumatoid Arthritis (RA)
The drug, ACTH, has been clinically available for many years as ACTHar gel and works well for rheumatoid arthritis, lupus, polymyositis and sarcoid. Because it was an “orphan drug” used for infantile paralysis and seizures, it was essentially unaffordable. The manufacturer now provides it at no cost, in some cases; some insurance companies cover it as well. A presentation on ACTHar gel was made this month, June 2019, at the European League Against RA (EULAR) annual meeting. Ask your rheumatologist if this drug is appropriate for you.
Repository Corticotropin Injection Appears To Be Generally Safe, Effective In Patients With Persistently Active RA Who Are Nonresponsive To DMARDs Or Corticosteroids, Study Suggests MedPage Today (6/17, Susman) reports, “Repository corticotropin injection (H.P. Acthar Gel) appeared to be generally safe and effective in patients with persistently active rheumatoid arthritis (RA) who were nonresponsive to disease-modifying antirheumatic drugs (DMARDs) or corticosteroids,” research indicated. The findings “of the manufacturer-sponsored study” were presented at the EULAR 2019 Congress.
Philadelphia, PA May 9, 2019… Main Line Rheumatology is excited to announce that we have added Hyon Ju Park, MD, to our staff of rheumatologists. Dr. Park has an impressive resume. She is board-certified in rheumatology and internal medicine, and certified in clinical densitometry (bone density studies). Dr. Park graduated Columbia University in 2003 with a degree in biochemistry, and graduated Mount Sinai School of Medicine in New York, in 2007. She completed a residency in Internal Medicine at Barnes Jewish Hospital in St. Louis, Missouri as well as a rheumatology fellowship and additional research fellowship at Washington University in St. Louis, Missouri.
Dr. Park has been an avid contributor to medical publishing including editorials, reviews, case reports and many book chapters. She has a special interest in lupus, vasculitis, and periodic fever syndromes.
Dr. Park is the mother of two children, and her husband is a cancer researcher at the University of Pennsylvania.